Obtained Patent for Infectious Disease Countermeasure System (Patent No. 7855205)

Obtained Patent for Infectious Disease Countermeasure System (Patent No. 7855205)

CartaNova

We have obtained a patent for a technology that supports appropriate antimicrobial prescription in infectious disease treatment.

This patent relates to an “Infectious Disease Countermeasure System, Infectious Disease Countermeasure Device, and Infectious Disease Countermeasure Program” that supports appropriate antibiotic prescribing based on patient severity and clinical information.

This technology aims to contribute to infectious disease management through medical DX by enabling:


rapid antimicrobial administration support for severe patients

promotion of appropriate antimicrobial use (AMR measures)

standardization and advancement of infectious disease treatment

medical support in resource-limited environments


■ Patent Information

Patent Number: Patent No. 7855205

Title of Invention: Infectious Disease Countermeasure System, Infectious Disease Countermeasure Device, and Infectious Disease Countermeasure Program

Patent Holder: CartaNova Inc.

CartaNova, Inc.

Seoul.

3F, 8, Samseong-ro 118-gil, Gangnam-gu, Seoul, Republic of Korea

Tokyo.

7F, The Argyle Aoyama, 2-14-4 Kitaaoyama, Minato-ku, Tokyo 107-0061, Japan

R&D Center.

A-1418, 301, Incheon tower-daero, Yeonsu-gu, Incheon, Republic of Korea

© 2026 CartaNova, Inc. All Rights Reserved.

CartaNova, Inc.

Seoul.

3F, 8, Samseong-ro 118-gil, Gangnam-gu, Seoul, Republic of Korea

Tokyo.

7F, The Argyle Aoyama, 2-14-4 Kitaaoyama, Minato-ku, Tokyo 107-0061, Japan

R&D Center.

A-1418, 301, Incheon tower-daero, Yeonsu-gu, Incheon, Republic of Korea

© 2026 CartaNova, Inc. All Rights Reserved.

CartaNova, Inc.

Seoul.

3F, 8, Samseong-ro 118-gil, Gangnam-gu, Seoul, Republic of Korea

Tokyo.

7F, The Argyle Aoyama, 2-14-4 Kitaaoyama, Minato-ku, Tokyo 107-0061, Japan

R&D Center.

A-1418, 301, Incheon tower-daero, Yeonsu-gu, Incheon, Republic of Korea

© 2025 CartaNova, Inc. All Rights Reserved.